Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Adverum Biotechnologies Inc (ADVM)

  • Event
  • June 06, 2022, 21:07 UTC
  • 17
  • 1 comments

(99% Neutral) Adverum Biotechnologies, Inc. (ADVM) Announces New Board Appointment

Comment Full text

Amarin Corporation Plc (AMRN)

  • Event
  • June 06, 2022, 20:36 UTC
  • 16
  • 1 comments

(99% Positive) AMARIN CORP PLC\UK (AMRN) Provides Update on expansion for our European launches while maintaining a strong

Comment Full text

Fulcrum Therapeutics (FULC)

  • Event
  • June 06, 2022, 20:30 UTC
  • 17
  • 1 comments

(99% Neutral) FULCRUM THERAPEUTICS, INC. (FULC) Announces Business Combination

Comment Full text

Solid Biosciences Inc (SLDB)

  • Event
  • June 06, 2022, 20:11 UTC
  • 17
  • 1 comments

(99% Neutral) Solid Biosciences Inc. (SLDB) Files Form 8-K

Comment Full text

Sera Prognostics Inc (SERA)

  • Event
  • June 06, 2022, 20:08 UTC
  • 17
  • 1 comments

(99% Neutral) SERA PROGNOSTICS, INC. (SERA) Files Form 8-K

Comment Full text

BioAtla Inc (BCAB)

  • Event
  • June 06, 2022, 20:05 UTC
  • 19
  • 1 comments

(99% Neutral) BIOATLA, INC. (BCAB) Announces Executive Changes

Comment Full text

Adicet Bio Inc (ACET)

  • Event
  • June 06, 2022, 20:01 UTC
  • 20
  • 1 comments

(10% Negative) Adicet Bio, Inc. (ACET) Announces Clinical Trial Timeline Adjustment

Comment Full text

Ionis Pharmaceuticals Inc (IONS)

  • Event
  • June 06, 2022, 20:00 UTC
  • 19
  • 1 comments

(99% Neutral) IONIS PHARMACEUTICALS, INC. (IONS) Announces Regulatory Update

Comment Full text

PMV Pharmaceuticals Inc (PMVP)

  • Event
  • June 06, 2022, 19:45 UTC
  • 19
  • 1 comments

(99% Neutral) PMV Pharmaceuticals, Inc. (PMVP) Announces Regulatory Update

Comment Full text

SAB Biotherapeutics (SABS)

  • Event
  • June 06, 2022, 17:35 UTC
  • 19
  • 1 comments

(99% Neutral) SAB BIOTHERAPEUTICS, INC. (SABS) Provides Update on patients for all phases of global clinical development

Comment Full text
  • Previous
  • 357
  • 358
  • 359
  • 360
  • 361
  • Next

Search

News categories

  • Technical Exchange News(11639)
  • Event(3896)
  • SEC News(226755)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(140566)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin